from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2688c/-

LFCtreatmentdescriptionclass of inhibitor

0.396

Amikacinug/mL Amikacintranslation

0.576

Cap5-10ug/mL Capreomycintranslation

0.399

Rox10-50 ug/mL Roxithromycintranslation

-0.352

SM2-5 ug/mL Streptomycintranslation

-0.045

Tet5-10 ug/mL Tetracyclinetranslation

-1.187

Rif0.2-5ug/mL Rifampicintranscription

-1.012

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.729

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.606

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.785

CPZ10-50 ug/mL Chlorpromazinerespiration

1.294

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.089

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.308

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.598

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.688

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.022

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.608

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.762

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.567

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.711

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.942

KCN5-20 ug/mL Potassium cyaniderespiration

0.877

NaN30.2-2 mM Sodium aziderespiration

0.885

Nigericin50 uM Nigericinrespiration

0.595

TRC10-150 ug/mL Triclosanrespiration

2.738

TRZ10-25 ug/mL Thioridazinerespiration

1.364

Valinomycin0.5-10 uM Valinomycinrespiration

0.640

ZnSO42 mM ZnSO4respiration

-0.414

menadione6-10 ug/mL Menadionerespiration

0.488

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.404

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.376

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.317

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.212

NRP_1Non-replicating persistence stage 1dosRassociated

-0.412

Amp0.2mg/mL AmpicillincellWall

-0.186

Cephalexin20-100 ug/mL CephalexincellWall

-0.595

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.702

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.683

EMB10-20 ug/mL EthambutolcellWall

-0.463

Eta12-40 ug/mL EthionamidecellWall

-0.507

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.710

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.332

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.314

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.125

BZA0.12 mg/mL BenzamidearomaticAmides

-0.192

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.205

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.833

H2O24 mM hydrogen peroxideDNAdamaging

-0.764

Levo10 ug/mL LevofloxacinDNAdamaging

-0.674

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.348

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.938

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.672

UVUV-irradiationDNAdamaging

0.698

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.051

Antimycin12.5-50 ug/mL Antimycin A?

-0.101

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.682

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.751

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.321

PA8240.2-2 ug/mL PA-824?

0.740

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.131

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.281

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.354

methoxatin10-20 ug/mL Methoxatin?